These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8277156)

  • 1. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
    Katona CL; Robertson MM; Abou-Saleh MT; Nairac BL; Edwards DR; Lock T; Burns R; Harrison DA; Taylor NS
    Int Clin Psychopharmacol; 1993; 8(4):323. PubMed ID: 8277156
    [No Abstract]   [Full Text] [Related]  

  • 2. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
    Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
    Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
    Howland RH
    Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
    [No Abstract]   [Full Text] [Related]  

  • 4. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
    Fontaine R; Ontiveros A; Elie R; Vézina M
    Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782
    [No Abstract]   [Full Text] [Related]  

  • 5. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M; Rosenbaum JF; McGrath PJ; Stewart JW; Amsterdam JD; Quitkin FM
    Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of fluoxetine and lithium in clinical practice.
    Hopwood SE; Bogle S; Wildgust HJ
    Int Clin Psychopharmacol; 1993; 8(4):325-7. PubMed ID: 8277157
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment resistant depression in the elderly: three cases.
    Seymour J; Wattis JP
    Int Clin Psychopharmacol; 1992; 7(1):55-7. PubMed ID: 1624758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capgras syndrome in association with lithium toxicity.
    Canagasabey B; Katona CL
    Br J Psychiatry; 1991 Dec; 159():879-81. PubMed ID: 1790464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory depression: a review with particular reference to the use of lithium augmentation.
    Katona CL
    Eur Neuropsychopharmacol; 1995; 5 Suppl():109-13. PubMed ID: 8775769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A; Fontaine R; Elie R
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions.
    Hawley CJ; Roberts AG; Baldwin DS
    Int Clin Psychopharmacol; 1994; 9(1):31-3. PubMed ID: 8195580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine.
    Bauer M; Linden M; Schaaf B; Weber HJ
    J Clin Psychopharmacol; 1996 Apr; 16(2):130-4. PubMed ID: 8690828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG; McElroy SL; Nixon RA
    Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Lancaster SG; Gonzalez JP
    Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
    Eisen A
    Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychiatrists' responses to failure of maintenance therapy with antidepressants.
    Byrne S; Rothschild AJ
    Psychiatr Serv; 1997 Jun; 48(6):835-7. PubMed ID: 9175196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.
    Stein G; Bernadt M
    Br J Psychiatry; 1993 May; 162():634-40. PubMed ID: 8149115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation.
    Hodgkiss AD
    Br J Psychiatry; 1995 May; 166(5):679. PubMed ID: 7503860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.